Compare Amphastar Pharmaceuticals Inc (AMPH) vs Ford Motor Company (F) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Ford (F) trades at $13.995, up 2.83% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative net income margin and ROE. Recent developments include a tentative labor agreement in Canada and JD Power quality recognition, though vehicle recalls and declining EV sales present headwinds.

Ford's valuation appears attractive with low P/E and P/S ratios, but fundamental weakness in profitability and rising debt levels warrant caution. Analyst consensus leans neutral with $14.89 price target, while institutional sentiment shows divided opinions. The stock offers value potential if operational improvements materialize, but execution risks and competitive pressures remain significant concerns.